Xenobiotic transporters: ascribing function from gene knockout and mutation studies.
暂无分享,去创建一个
[1] H. Rosing,et al. Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics , 2006, Clinical Cancer Research.
[2] M. Hayden,et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.
[3] H. Faulstich,et al. Identification of phalloidin uptake systems of rat and human liver. , 2004, Biochimica et biophysica acta.
[4] Richard J. Thompson,et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency , 2006, Hepatology.
[5] Hiroshi Omote,et al. A human transporter protein that mediates the final excretion step for toxic organic cations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] Hirotaka Matsuo,et al. Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.
[7] T. Gilliam,et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. , 1999, Human molecular genetics.
[8] C. Klaassen,et al. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[9] D D Breimer,et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. , 2000, The Journal of clinical investigation.
[10] P. Borst,et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.
[11] P. Dawson,et al. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). , 1997, The Journal of clinical investigation.
[12] J. Sundberg,et al. Targeted Ablation of the Abcc6 Gene Results in Ectopic Mineralization of Connective Tissues , 2005, Molecular and Cellular Biology.
[13] P. Borst,et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] Stuart J McLarnon,et al. Iron handling and gene expression of the divalent metal transporter, DMT1, in the kidney of the anemic Belgrade (b) rat. , 2003, Kidney international.
[15] P. Dawson,et al. The Heteromeric Organic Solute Transporter α-β, Ostα-Ostβ, Is an Ileal Basolateral Bile Acid Transporter* , 2005, Journal of Biological Chemistry.
[16] C. Klaassen,et al. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[17] Kim L R Brouwer,et al. The Important Role of Bcrp (Abcg2) in the Biliary Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Mice , 2006, Molecular Pharmacology.
[18] N. Amizuka,et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Choudhuri,et al. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[20] Jonathan C. Cohen,et al. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500115-JLR200 , 2005, Journal of Lipid Research.
[21] K. Millen,et al. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. , 2006, Endocrinology.
[22] H. Kusuhara,et al. Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. , 2004, Endocrinology.
[23] L. Thurfjell,et al. Mapping Pathological 99mTc-d,l-Hexamethylpropylene Amine Oxime Uptake in Alzheimer’s Disease and Frontal Lobe Dementia with SPECT , 2001, Dementia and Geriatric Cognitive Disorders.
[24] R. Palmiter,et al. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Masuda. Functional characteristics and pharmacokinetic significance of kidney-specific organic anion transporters, OAT-K1 and OAT-K2, in the urinary excretion of anionic drugs. , 2003, Drug metabolism and pharmacokinetics.
[26] S. Vavricka,et al. Regional Distribution of Solute Carrier mRNA Expression Along the Human Intestinal Tract , 2007, Drug Metabolism and Disposition.
[27] P. Wielinga,et al. Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy , 2004, Molecular and Cellular Biology.
[28] N. Ballatori. Biology of a Novel Organic Solute and Steroid Transporter, OSTΑ-OSTβ , 2005 .
[29] V. Divoky,et al. Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake. , 2005, Blood.
[30] M. Kool,et al. Peptide transport by the multidrug resistance protein MRP1. , 2001, Cancer research.
[31] Y. Sugiyama,et al. Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. , 2002, American journal of physiology. Endocrinology and metabolism.
[32] J. Schellens,et al. Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.
[33] J. Schuetz,et al. The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.
[34] Y. Asano,et al. P-glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro. , 2001, Journal of the American Society of Nephrology : JASN.
[35] F. Kuipers,et al. Dietary plant sterols accumulate in the brain. , 2006, Biochimica et biophysica acta.
[36] R. Keep,et al. Role and Relevance of Peptide Transporter 2 (PEPT2) in the Kidney and Choroid Plexus: In Vivo Studies with Glycylsarcosine in Wild-Type and PEPT2 Knockout Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.
[37] J. Mercer,et al. ATP7B mediates vesicular sequestration of copper: insight into biliary copper excretion. , 2006, Gastroenterology.
[38] Jae-Young Koh,et al. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Wijnholds,et al. Multidrug Resistance Protein 1 Protects the Oropharyngeal Mucosal Layer and the Testicular Tubules against Drug-induced Damage , 1998, The Journal of experimental medicine.
[40] P. Dawson,et al. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. , 2005, The Journal of biological chemistry.
[41] A. Klein-Szanto,et al. Analysis of the In Vivo Functions of Mrp3 , 2005, Molecular Pharmacology.
[42] L. Pawlikowska,et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport , 2006, Hepatology.
[43] Xingguo Cheng,et al. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE , 2005, Drug Metabolism and Disposition.
[44] A. Schinkel,et al. Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations , 2003, Molecular and Cellular Biology.
[45] Per Artursson,et al. Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.
[46] P. Borst,et al. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene , 2005, Hepatology.
[47] G. Mitchell,et al. Carnitine transport by organic cation transporters and systemic carnitine deficiency. , 2001, Molecular genetics and metabolism.
[48] Z. Gregus,et al. Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[49] T. Abe,et al. Identification and characterization of novel rat and human gonad-specific organic anion transporters. , 2003, Molecular endocrinology.
[50] W. Fung-Leung,et al. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. , 2001, Gastroenterology.
[51] C. Ackerley,et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[52] T. Abe,et al. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Boyer,et al. Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.
[54] V. Vallon,et al. Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice* , 2006, Journal of Biological Chemistry.
[55] H. Koepsell,et al. Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene , 2001, Molecular and Cellular Biology.
[56] O. van Tellingen,et al. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. , 1999, The Journal of clinical investigation.
[57] H. Rosing,et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[58] N. Ballatori. Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta. , 2005, Experimental biology and medicine.
[59] Yuichi Sugiyama,et al. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. , 2007, Journal of the American Society of Nephrology : JASN.
[60] C. Klaassen,et al. Intestinal absorption of cadmium is associated with divalent metal transporter 1 in rats. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[61] R. Palmiter,et al. Mouse zinc transporter 1 gene provides an essential function during early embryonic development , 2004, Genesis.
[62] Jonathan C. Cohen,et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[63] B. Neuschwander‐Tetri,et al. The hepatocellular bile acid transporter Ntcp facilitates uptake of the lethal mushroom toxin α-amanitin , 2004, Archives of Toxicology.
[64] P. Dawson,et al. Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice* , 2003, Journal of Biological Chemistry.
[65] A. Bonci,et al. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference , 2004, Nature Neuroscience.
[66] N. Maeda,et al. A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol , 2004, BMC medicine.
[67] Yuichi Sugiyama,et al. Characterization of the Uptake of Organic Anion Transporter (OAT) 1 and OAT3 Substrates by Human Kidney Slices , 2007, Journal of Pharmacology and Experimental Therapeutics.
[68] Yuichi Sugiyama,et al. Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen , 2005, Molecular Pharmacology.
[69] Yuichi Sugiyama,et al. Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir , 2007, Molecular Pharmacology.
[70] P. Bosma,et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[71] Jianjun Liu,et al. Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis* , 2004, Journal of Biological Chemistry.
[72] R. Keep,et al. Targeted Disruption of the PEPT2 Gene Markedly Reduces Dipeptide Uptake in Choroid Plexus* , 2003, The Journal of Biological Chemistry.
[73] V. Ling,et al. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.
[74] F. Russel,et al. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. , 2004, Journal of the American Society of Nephrology : JASN.
[75] Peter J. Meier,et al. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.
[76] A. Dahan,et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[77] D. Beier,et al. Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice* , 2002, The Journal of Biological Chemistry.
[78] V. Ling,et al. Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P‐glycoprotein , 2003, Hepatology.
[79] G. L. Youngblood,et al. Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. , 2004, American journal of physiology. Renal physiology.
[80] T. Visser,et al. Mechanisms of Disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8 , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[81] C. Klaassen,et al. The presence of xenobiotic transporters in rat placenta. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[82] R. Kim,et al. Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans , 2007, Clinical pharmacology and therapeutics.
[83] H. Kusuhara,et al. Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[84] S. Brennecke,et al. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[85] Luquan Wang,et al. Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption , 2022 .